We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBAX icon
4576
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.71B
$400K ﹤0.01%
8,928
-1,640
-16% -$68.3K
FMAT icon
4577
Fidelity MSCI Materials Index ETF
FMAT
$584M
$398K ﹤0.01%
12,906
-1,252
-9% -$35.9K
FUNC icon
4578
First United
FUNC
$285M
$398K ﹤0.01%
29,764
+158
+0.5% +$2.24K
DNR
4579
DELISTED
Denbury Resources, Inc.
DNR
$398K ﹤0.01%
1,445,398
+112,990
+8% +$33.9K
SDOW icon
4580
ProShares UltraPro Short Dow 30
SDOW
$144M
$396K ﹤0.01%
1,029
+843
+453% +$419K
LMNL
4581
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$394K ﹤0.01%
3,647
+152
+4% +$13.4K
DURA icon
4582
VanEck Durable High Dividend ETF
DURA
$38.5M
$393K ﹤0.01%
15,238
-13,767
-47% -$351K
LND
4583
BrasilAgro
LND
$374M
$393K ﹤0.01%
106,123
+947
+0.9% +$3.43K
RUSHA icon
4584
Rush Enterprises Class A
RUSHA
$6.2B
$392K ﹤0.01%
21,262
+12,208
+135% +$203K
GWRS icon
4585
Global Water Resources
GWRS
$206M
$390K ﹤0.01%
36,884
+1,299
+4% +$13.7K
CMU
4586
DELISTED
MFS High Yield Municipal Trust
CMU
$389K ﹤0.01%
95,592
-23,423
-20% -$93.4K
EMCB icon
4587
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$98.7M
$389K ﹤0.01%
5,406
+1,991
+58% +$136K
VAL
4588
DELISTED
Valaris plc Class A Ordinary Share
VAL
$389K ﹤0.01%
595,739
-1,826,276
-75% -$1.03M
BTAI icon
4589
BioXcel Therapeutics
BTAI
$24.9M
$388K ﹤0.01%
457
+178
+64% +$116K
EDC icon
4590
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$152M
$388K ﹤0.01%
8,711
+6,375
+273% +$239K
CVGI icon
4591
Commercial Vehicle Group
CVGI
$154M
$387K ﹤0.01%
133,924
+14,806
+12% +$30.8K
THER
4592
DELISTED
THERATECHNOLOGIES INC COM
THER
$387K ﹤0.01%
192,389
-37,513
-16% -$75.5K
DMF
4593
DELISTED
BNY Mellon Municipal Income
DMF
$386K ﹤0.01%
46,426
-6,313
-12% -$52.5K
LORL
4594
DELISTED
Loral Space and Communications, Inc.
LORL
$386K ﹤0.01%
19,787
-49,143
-71% -$920K
FC icon
4595
Franklin Covey
FC
$242M
$385K ﹤0.01%
17,984
+14,743
+455% +$299K
OGI
4596
Organigram Holdings
OGI
$132M
$385K ﹤0.01%
61,672
+51,706
+519% +$348K
RPTX
4597
DELISTED
Repare Therapeutics
RPTX
$385K ﹤0.01%
+12,421
New +$399K
FRGI
4598
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$385K ﹤0.01%
60,457
-78,500
-56% -$544K
KURA icon
4599
Kura Oncology
KURA
$800M
$384K ﹤0.01%
23,558
+8,874
+60% +$128K
FCOR icon
4600
Fidelity Corporate Bond ETF
FCOR
$347M
$383K ﹤0.01%
6,904
+490
+8% +$26.2K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.